Distinct molecular pathways supporting Sjögren's Disease clusters and disease progression
Listen to this summary
The authors investigate the blood transcriptomic signatures and disease progression in three distinct clusters of Sjögren's disease (SjD): B-cell active with low symptoms (BALS), high systemic activity (HSA), and low systemic activity with high symptoms (LSAHS). They find that both BALS and HSA exhibit significant interferon signaling, with BALS showing a hyperinflammatory state linked to disease progression, while HSA is characterized by pathways promoting proliferation and metabolism. These insights suggest potential mechanisms underlying disease progression in SjD and highlight the importance of distinct molecular pathways in different patient clusters.
This is one of 33,000+ journals available on OSLR. Try it free for 14 days.
Free 14-day trial. 33,000+ journals. Cancel anytime.

More from Arthritis & rheumatology (Hoboken, N.J.)
View all →Jun 9, 2026 · Arthritis & rheumatology (Hoboken, N.J.)
Development and Validation of the ALARN Model: A Predictive Mortality Score for Antisynthetase Syndrome
Jun 8, 2026 · Arthritis & rheumatology (Hoboken, N.J.)
Homocitrullinated Peptides Drive Pro-Inflammatory T-Cell Responses in a Humanized Mouse Model of Rheumatoid Arthritis
Jun 4, 2026 · Arthritis & rheumatology (Hoboken, N.J.)
Multimodal peripheral blood immunophenotyping and single cell epigenetic analysis of knee osteoarthritis reveals expansion and epigenetic dysregulation of regulatory T-cell and nonclassical monocyte populations
Jun 3, 2026 · Arthritis & rheumatology (Hoboken, N.J.)
Fine particulate matter constituents, ozone, and systemic lupus erythematosus: A large general-population cohort analysis with extended quantile g-computation
Jun 1, 2026 · Arthritis & rheumatology (Hoboken, N.J.)
Integrated Clinical and Proteomic Profiling of CD19 CAR-T Cell Therapy in Progressive Systemic Sclerosis
Jun 1, 2026 · Arthritis & rheumatology (Hoboken, N.J.)
Human Fibroblast-Myeloid cell tissue atlas across lung, synovium, skin and heart
More in Pediatrics
View all →Nov 20, 2026 · Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Effect of a Multidisciplinary Intervention on Fatigue in Lymphoma Survivors With Persistent Fatigue: A Randomized Controlled Trial (the REFUEL trial).
Nov 20, 2026 · Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Reach of State-Mandated Insurance Coverage for Fertility Preservation in Patients With Cancer.
Nov 20, 2026 · Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Alectinib as Neoadjuvant Treatment in Potentially Resectable Stage III Anaplastic Lymphoma Kinase-Positive Non-Small Cell Lung Cancer: ALNEO Phase II Trial (GOIRC-01-2020-ML42316).
Nov 20, 2026 · Hormone research in paediatrics
Post-Menarcheal Height Gain After Gonadotropin-Releasing Hormone Agonist Treatment in Girls with Central Precocious Puberty.
Nov 20, 2026 · Hormone research in paediatrics
JUVENILE IDIOPATHIC ARTHRITIS IN CHILDREN WITH TYPE 1 DIABETES: IMPACT OF CURRENT MEDICAL TREATMENT OPTIONS ON ANTHROPOMETRY AND METABOLIC CONTROL.
Nov 20, 2026 · European heart journal
Acute pulmonary embolism: long-term cause-specific mortality in a Chinese nationwide registry.
"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."
Dr. Jennifer Thompson
Portland, OR


